Interleukin Genetics, Inc. introduces PerioPredict[TM], the company's new, next-generation version of the PST[R] genetic risk test for periodontal disease. Like the original PST[R] test, Perio-Predict[TM] measures variations in the genes for Interleukin-1 (IL-1), a key mediator of inflammation, and identifies individuals who are at an increased risk for more severe periodontal disease. The new and improved sample collection device now incorporates a simple, easy-to-use cheek swab. The new test also utilizes an expansion of previous genetic markers that now cover all major ethnic groups including Hispanic, African-American and Asian, in addition to Caucasian. Quick, easy and painless, the test is performed by dental hygienists or dentists in about a minute during a routine examination or prophylaxis. The sample is then sent to Interleukin Genetics, Inc., a CLIA-certified genetics laboratory, for analysis. Test results are returned to the dentist in about two weeks. For more information, visit www.PerioPredict.com.